Study on a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Compared to Two Meningococcal Reference Vaccines in European Toddlers

Trial Identifier: MEQ00065
Sponsor: Sanofi Pasteur, a Sanofi Company
Start Date: September 2019
Primary Completion Date: October 2020
Study Completion Date: October 2020
Condition: Meningococcal Immunisation; Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
DENMARK Aarhus, DENMARK, 8200
DENMARK Hvidovre, DENMARK, 2650
DENMARK Odense, DENMARK, 5000
FINLAND Espoo, FINLAND, 02230
FINLAND Helsinki, FINLAND, 00100
FINLAND Järvenpää, FINLAND, 04400
FINLAND Kokkola, FINLAND, 67100
FINLAND Oulu, FINLAND, 90220
FINLAND Pori, FINLAND, 28100
FINLAND Seinäjoki, FINLAND, 60100
FINLAND Tampere, FINLAND, 33100
FINLAND Turku, FINLAND, 20520
GERMANY Bönnigheim, GERMANY, 74357
GERMANY Bramsche, GERMANY, 49565
GERMANY Bretten, GERMANY, 75015
GERMANY Erfurt, GERMANY, 99086
GERMANY Hamburg, GERMANY, 22415
GERMANY Herxheim, GERMANY, 76863
GERMANY Hürth, GERMANY, 50354
GERMANY Itzehoe, GERMANY, 25524
GERMANY Mannheim, GERMANY, 68161
GERMANY Mönchengladbach, GERMANY, 41236
GERMANY Schönau, GERMANY, 83471
GERMANY Schwaigern, GERMANY, 74193
GERMANY Schweigen, GERMANY, 76889
GERMANY Tauberbischofsheim, GERMANY, 97941
GERMANY Tuttlingen, GERMANY, 78532
GERMANY Wolfsburg, GERMANY, 38448